Cancer warning for popular diet drug Belviq after overweight patients in trial to test its safety for those at risk for heart disease developed tumors

KONICA MINOLTA DIGITAL CAMERA

The US Food and Drug Administration (FDA) is warning the American public that a weight-loss drug may increase the risk of cancer.

In a statement on Tuesday, the FDA said a clinical trial had shown that those on a he prescription medication Belviq, also known in its generic form as lorcaserin, may face higher cancer risks than the general population does.

The trial was meant to evaluate whether the drug was safe to take for obese patients who were at risk of heart disease but, at the end of the study period, more participants had tumors after taking Belviq than a placebo.

Read more of the original article from DailyMail

essentialformulas.com
SHARE